Remdesivir Recruiting Phase 3 Trials for Covid-19 ARDS / Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04678739Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial
NCT04693026Efficacy of Ramdicivir and Baricitinib for the Treatment of Severe COVID 19 Patients